Plus Therapeutics Inc (PSTV)
1.2400 +0.0700 (+5.98%) 01/21/25 [NASDAQ]
1.2200 x 300 1.2400 x 100
Realtime by (Cboe BZX)
1.2200 x 300 1.2400 x 100
Realtime - - (-) -
for Tue, Jan 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -13,316 | -20,275 | -13,399 | -8,241 | -10,887 |
Depreciation Amortization | 818 | 1,008 | 941 | 950 | 1,446 |
Accounts receivable | N/A | N/A | N/A | 1,169 | -1,203 |
Other Working Capital | -1,116 | 5,597 | 1,238 | 119 | -938 |
Other Operating Activity | 763 | 698 | 940 | -2,431 | 5,676 |
Operating Cash Flow | $-12,851 | $-12,972 | $-10,280 | $-8,434 | $-5,906 |
Cash Flows From Investing Activities | |||||
PPE Investments | -160 | -509 | -82 | -93 | -67 |
Net Acquisitions | N/A | N/A | N/A | N/A | 5,637 |
Other Investing Activity | 0 | -250 | 0 | -400 | 0 |
Investing Cash Flow | $-160 | $-759 | $-82 | $-493 | $5,570 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -1,608 | -1,608 | -276 | -5,424 | -3,823 |
Common Stock Issued | 5,527 | 15,832 | 20,692 | 5,105 | 16,454 |
Common Stock Repurchased | -126 | N/A | N/A | N/A | N/A |
Other Financing Activity | -348 | -773 | 0 | 0 | 0 |
Financing Cash Flow | $3,445 | $13,451 | $20,416 | $-319 | $12,631 |
Exchange Rate Effect | N/A | N/A | N/A | N/A | -4 |
Beginning Cash Position | 18,120 | 18,400 | 8,346 | 17,592 | 5,301 |
End Cash Position | 8,554 | 18,120 | 18,400 | 8,346 | 17,592 |
Net Cash Flow | $-9,566 | $-280 | $10,054 | $-9,246 | $12,291 |
Free Cash Flow | |||||
Operating Cash Flow | -12,851 | -12,972 | -10,280 | -8,434 | -5,906 |
Capital Expenditure | -160 | -509 | -144 | -93 | -67 |
Free Cash Flow | -13,011 | -13,481 | -10,424 | -8,527 | -5,973 |